Abstract
Under the Japanese health insurance system, medicines undergoing therapeutic drug monitoring (TDM) can be billed for medical fees if they meet the specified requirements. In Japan, TDM of vancomycin, teicoplanin, aminoglycosides, and voriconazole, which are used for the treatment of infectious diseases, is common practice. This means the levels of antibiotics are measured in-house using chromatography or other methods. In some facilities, the blood and/or tissue concentrations of other non-TDM drugs are measured by HPLC and are applied to treatment, which is necessary for personalized medicine. This review describes personalized medicine based on the use of chromatography as a result of the current situation in Japan.
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference86 articles.
1. Development of a Practical HPLC Method for In-hospital Quantitation of Various Medicinal Drugs at Blood Levels
2. Committee on Toxicology Laboratories; Japanese Society for Clinical Toxicology [Survey of analytical works for drugs at emergency and critical care centers with high-performance instruments provided by the Ministry of Health and Welfare (at present: Ministry of Health, Labour, and Welfare) in fiscal 1998—Continuation of survey with 2008 survey results as point of reference];Saito;Chudoku Kenkyu,2013
3. Current state of drug analysis in Japanese emergency departments: a nationwide survey
4. Practice Guidelines for Therapeutic Drug Monitoring of Antimicrobials in 2022. (Executive Summary)-the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
http://www.chemotherapy.or.jp/guideline/tdm2022.html
5. Third-generation cephalosporins
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献